Does OLMESARTAN Cause Hypernatraemia? 7 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Hypernatraemia have been filed in association with OLMESARTAN. This represents 0.3% of all adverse event reports for OLMESARTAN.
7
Reports of Hypernatraemia with OLMESARTAN
0.3%
of all OLMESARTAN reports
3
Deaths
4
Hospitalizations
How Dangerous Is Hypernatraemia From OLMESARTAN?
Of the 7 reports, 3 (42.9%) resulted in death, 4 (57.1%) required hospitalization, and 3 (42.9%) were considered life-threatening.
Is Hypernatraemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OLMESARTAN. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does OLMESARTAN Cause?
Sprue-like enteropathy (391)
Diarrhoea (313)
Gastrointestinal disorder (276)
Acute kidney injury (209)
Weight decreased (197)
Hypotension (176)
Drug ineffective (131)
Dizziness (115)
Hypokalaemia (110)
Dyspnoea (106)
What Other Drugs Cause Hypernatraemia?
TOLVAPTAN (235)
FUROSEMIDE (192)
LITHIUM (186)
SODIUM (136)
LAMOTRIGINE (90)
VALPROIC ACID (88)
OLANZAPINE (87)
METFORMIN (79)
QUETIAPINE (77)
ARIPIPRAZOLE (69)
Which OLMESARTAN Alternatives Have Lower Hypernatraemia Risk?
OLMESARTAN vs OLMESARTAN MEDOXOMIL
OLMESARTAN vs OLMETEC
OLMESARTAN vs OLODATEROL
OLMESARTAN vs OLODATEROL\TIOTROPIUM
OLMESARTAN vs OLOPATADINE